BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12900211)

  • 1. Retroviral gene therapy--where now?
    Günzburg WH
    Trends Mol Med; 2003 Jul; 9(7):277-8. PubMed ID: 12900211
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukemia case triggers tighter gene-therapy controls.
    Bonetta L
    Nat Med; 2002 Nov; 8(11):1189. PubMed ID: 12411927
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gene therapy for severe combined immunodeficiency linked to chromosome X].
    Fischer A
    Hematol Cell Ther; 1997 Apr; 39(2):97. PubMed ID: 9229544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gene therapy using retroviral vectors].
    Hanawa H; Shimada T
    Uirusu; 2003 Dec; 53(2):177-83. PubMed ID: 15071956
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapy for primary immunodeficiencies.
    Fischer A; Hacein-Bey Abina S; Touzot F; Cavazzana M
    Clin Genet; 2015 Dec; 88(6):507-15. PubMed ID: 25708106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A voluntary moratorium?
    Verma IM
    Mol Ther; 2003 Feb; 7(2):141. PubMed ID: 12638540
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.
    Onodera M; Nelson DM; Sakiyama Y; Candotti F; Blaese RM
    Acta Haematol; 1999; 101(2):89-96. PubMed ID: 10202239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful gene therapy for severe combined immunodeficiency.
    Rosen FS
    N Engl J Med; 2002 Apr; 346(16):1241-3. PubMed ID: 11961154
    [No Abstract]   [Full Text] [Related]  

  • 9. [Safety of retroviral vectors in gene therapy].
    Bogoslovskaia EV; Glazkova DV; Shipulin GA; Pokrovskiĭ VV
    Vestn Ross Akad Med Nauk; 2012; (10):55-61. PubMed ID: 23240501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy of X-linked severe combined immunodeficiency.
    Hacein-Bey-Abina S; de Saint Basile G; Cavazzana-Calvo M
    Methods Mol Biol; 2003; 215():247-59. PubMed ID: 12512304
    [No Abstract]   [Full Text] [Related]  

  • 11. ADA-SCID Gene Therapy Endorsed By European Medicines Agency For Marketing Authorization.
    Ylä-Herttuala S
    Mol Ther; 2016 Jun; 24(6):1013-1014. PubMed ID: 27324442
    [No Abstract]   [Full Text] [Related]  

  • 12. Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID.
    Schimmer J; Breazzano S
    Hum Gene Ther Clin Dev; 2016 Jun; 27(2):57-61. PubMed ID: 27267267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issues.
    Medin JA; Fowler DH
    J Cell Biochem Suppl; 2002; 38():46-54. PubMed ID: 12046849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Le Deist F; De Saint Basile G; Cavazzana-Calvo M
    Adv Exp Med Biol; 2001; 495():199-204. PubMed ID: 11774567
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gene therapy and clinical trials].
    Tazawa R; Pradono P; Hagiwara K; Nukiwa T
    Nihon Rinsho; 2002 May; 60 Suppl 5():625-9. PubMed ID: 12101750
    [No Abstract]   [Full Text] [Related]  

  • 16. Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome.
    Qazilbash MH; Walsh CE; Russell SM; Noguchi M; Mann MM; Leonard WJ; Liu JM
    J Hematother; 1995 Apr; 4(2):91-8. PubMed ID: 7633846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.
    Hacein-Bey-Abina S; von Kalle C; Schmidt M; Le Deist F; Wulffraat N; McIntyre E; Radford I; Villeval JL; Fraser CC; Cavazzana-Calvo M; Fischer A
    N Engl J Med; 2003 Jan; 348(3):255-6. PubMed ID: 12529469
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene therapy for SCID--a complication after remarkable progress.
    Buckley RH
    Lancet; 2002 Oct; 360(9341):1185-6. PubMed ID: 12401240
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy. Second child in French trial is found to have leukemia.
    Marshall E
    Science; 2003 Jan; 299(5605):320. PubMed ID: 12531981
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
    McCormack MP; Rabbitts TH
    N Engl J Med; 2004 Feb; 350(9):913-22. PubMed ID: 14985489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.